MCRPC

Clinical trials for MCRPC explained in plain language.

Never miss a new study

Get alerted when new MCRPC trials appear

Sign up with your email to follow new studies for MCRPC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 2 Completed 1

New immune cell therapy tested for Tough-to-Treat prostate cancer

Disease control Completed

This early-stage study tested a new cell therapy called INKmune in men with advanced prostate cancer that had spread and stopped responding to standard hormone treatments. The main goals were to find the safest and most effective dose and to see how well patients tolerated the tr…

Matched conditions: MCRPC

Phase: PHASE1, PHASE2 • Sponsor: Inmune Bio, Inc. • Aim: Disease control

Last updated Mar 23, 2026 15:14 UTC

MCRPC

Get alerted when new MCRPC trials appear

New immune cell therapy tested for Tough-to-Treat prostate cancer